Tagged with EG

Pharma Ferring Italy’s CEO discusses the affiliate’s successful management strategy, new products, new partnerships, and the potential of the Italian market. When we last interviewed you in 2009, you were focused on: (1) reinforcing the local organization’s structure, (2) successfully launching Firmagon, and (3) forging new partnerships in the IBD field.…

Pharma Five days before the January 25th revolution of 2011, Rameda changed ownership and CEO Amr Morsy set out to turn-around the mismanaged business. Five years later, revenues are up 4.5 times and the company is building a position as a regional leader in the Middle Eastern nutraceuticals market. In 2011,…

Pharma Tabuk Pharmaceuticals, the largest private Saudi pharmaceutical company with commercial operations in 25 countries in middle east and 5 European countries with a portfolio of more than 250 products, chose Egypt to consolidate its international presence in the Middle East and North Africa. The general manager for Egypt and Sudan…

Pharma Paul Korte, General Manager for Janssen in the Netherlands, highlights the strategic move and leadership position taken up by Janssen in the oncology field, and calls on Dutch healthcare stakeholders to adopt the positive and collaborative attitude that will ensure Dutch patients can still expect to access the most innovative…

Pharma Dr. Ermano Buratti, General Manager for Astellas Pharma in Italy, discusses the company’s evolution as it enters its second decade, the importance of partnering with the government on reimbursement, the current state and need for change in the country’s healthcare system, and his efforts to put Astellas in a position…

Pharma Takeda’s goal is to become a trusted and reliable partner in the healthcare system by better understanding patients’ needs. Aarnoud Overkamp, general manager of the Dutch subsidiary, shares his perspective on the challenges faced by the local healthcare system, the importance of Takeda-ism in the organization, and finding innovative ways…

Pharma In 2008 Focus Reports interviewed Mr. Federico Seghi Recli as he prepared to transform Molteni Farmaceutici into an International specialty pharma company. Today we catch up on the progress, investments and strategic decisions which have been made since, and ask how he plans to continue his remarkable growth as well…

Pharma Albert Denoon (AB) and Jeff Hampton (JH) illustrate how the Crossroads and Campbell Institutes, two non-profit organizations funded by Baroque Medical, are well positioned to address South Africa’s current gaps in medical training. They also depict the key success factors that have allowed the company to become the leading distributor…

Pharma Serving as the leader of two companies – Platine, a CRO, and Indicia, a CMO – Stephane Legastelois, in his own words, challenges himself by wearing two different hats. Offering his unique views from two angles of the healthcare industry, Mr. Legastelois opens up as to why France, and particularly…

Pharma Egypt can boast some of the most modern manufacturing sites in the Arab world. The CEO of Future Pharmaceutical Industries discusses the importance of promoting exports, the ambitious plans of the company as well as the importance of education in leveraging the full potential of the country. How would you assess the…

Pharma Starting as a pharmacy chain, Hefny Pharma Group has developed into a group focused on manufacturing, importing and distributing pharmaceutical products to the Egyptian market, with an eye on the specific needs of patients. The founder and CEO discusses the vision behind the creation of the group, the market opportunities…

Pharma The chairman of Egypt’s largest holding company for pharmaceutical manufacturers, ACDIMA, shares his vision for how Egyptian manufacturers can enhance their competitiveness in the coming years, and extend their activities further up the value chain into API production and R&D activities. How well prepared are Egyptian companies to compete in…